continued from page 1 Accreditation could be denied if their products are deemed too expensive to me...
continued from page 1
Accreditation could be denied if their products are deemed too expensive to meet the standards set by the ABI, leading to a competition issue involving the OFT.
SALTR has apparently contacted a lawyer in order to determine what the implications of its proposed system would be on smaller companies. The FSA is aware of project SALTR. A spokesman for the regulator said that life and long term business would still be regulated by PIA rules concerning advice but broadly speaking the FSA does not regulate how products are structured.
More than £167,000 raised
Beware ‘temporary’ vulnerability
Partner Insight: A renewed focus on 'knowledge-intensive' companies should help investors realise that these entrepreneurial companies are found in sectors other than biotech or technology.
Celtic WM and Active Wealth